The stroma reaction myofibroblast: A key player in the control of tumor cell behavior

International Journal of Developmental Biology

Volumn 48, Issue 5-6, 2004, Pages 509-517

  Desmoulière, Alexis ^a   Guyot, Christelle ^a   Gabbiani, Giulio ^b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Desmoplasia; Hepatocellular carcinoma; Myofibroblast; Stroma reaction

Indexed keywords

ALPHA ACTIN; ALPHA SMOOTH MUSCLE ACTIN; CD34 ANTIGEN; COLLAGEN; COLLAGENASE 3; DESMIN; EPIDERMAL GROWTH FACTOR; FIBRILLIN; FIBRONECTIN; GELATINASE A; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; KERATINOCYTE GROWTH FACTOR; MACROPHAGE ELASTASE; MYOSIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN BCL 2; SCATTER FACTOR; SCLEROPROTEIN; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; CANCER INVASION; CONNECTIVE TISSUE CELL; EMBRYO DEVELOPMENT; EPITHELIUM CELL; EPITHELIUM TUMOR; EXTRACELLULAR MATRIX; FIBROSIS; HUMAN; KIDNEY FIBROSIS; LIVER CELL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MESENCHYME; MYOFIBROBLAST; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; STROMA CELL; TUMOR GROWTH; VASCULAR SMOOTH MUSCLE; WOUND HEALING;

ACTINS; ANIMALS; ANTIGENS, CD34; CARCINOMA, HEPATOCELLULAR; FIBROBLASTS; FIBROSIS; HUMANS; LIVER NEOPLASMS; MODELS, BIOLOGICAL; MUSCLE, SMOOTH; MUSCLES; NEOPLASM INVASIVENESS; NEOPLASMS; STROMAL CELLS; WOUND HEALING;

EID: 5444261094     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.041802ad     Document Type: Review

References (90)

1. ABE, R., DONNELLY, S.C., PENG, T., BUCALA, R. and METZ, C.N. (2001). Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166:7556-7562.
2. ANKOMA-SEY, V., WANG, Y. and DAI, Z. (2000). Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells. Hepatology 31:141-148.
3. ASHWORTH, J.L., MURPHY, G., ROCK, M.J., SHERRATT, M.J., SHAPIRO, S.D., SHUTTLEWORTH, C.A. and KIELTY, C.M. (1999). Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling. Biochem. J. 340:171-181.
4. BASSET, P., BELLOCQ, J.P., WOLF, C., STOLL, I., HUTIN, P., LIMACHER, J.M., PODHAJCER, O.L., CHENARD, M.P., RIO, M.C. and CHAMBON, P. (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704.
5. BIOULAC-SAGE, P., BLANC, J.F., LEPREUX, S., BALABAUD, C., ROSENBAUM, J. and DESMOULIÈRE, A. (2000). Cirrhosis: forever? Gastroenterol. Clin. Biol. 24:877-882.
6. BORDER, W.A. and RUOSLAHTI, E. (1992). Transforming growth factor-beta in disease: the dark side of tissue repair. J. Clin. Invest. 90:1-7.
7. BROCKS, B., GARIN-CHESA, P., BEHRLE, E., PARK, J.E., RETTIG, W.J., PFIZENMAIER, K. and MOOSMAYER, D. (2001). Species-crossreactive scFv against the tumor stroma marker "fibroblast activation protein" selected by phage display from an immunized FAP-/- knock-out mouse. Mol. Med. 7:461-469.
8. BUCALA, R., SPIEGEL, L.A., CHESNEY, J., HOGAN, M. and CERAMI, A. (1994). Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med. 1:71-81.
9. CARMELIET, P. and JAIN, R.K. (2000). Angiogenesis in cancer and other diseases. Nature 407:249-257.
10. CHIQUET-EHRISMANN, R., TANNHEIMER, M., KOCH, M., BRUNNER, A., SPRING, J., MARTIN, D., BAUMGARTNER, S. and CHIQUET, M. (1994). Tenascin-C expression by fibroblasts is elevated in stressed collagen gels. J. Cell Biol. 127:2093-2101.
11. CINTORINO, M., BELLIZZI DE MARCO, E., LEONCINI, P., TRIPODI, S.A., XU, L.J., SAPPINO, A.P., SCHMITT-GRÄFF, A. and GABBIANI, G. (1991). Expression of alpha-smooth-muscle actin in stromal cells of the uterine cervix during epithelial neoplastic changes. Int. J. Cancer 47:843-846.
12. COUSSENS, L.M. and WERB, Z. (2002). Inflammation and cancer. Nature 420:860-867.
13. DARBY, I., SKALLI, O. and GABBIANI, G. (1990). Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab. Invest. 63:21-29.
14. DARBY, I.A., BISUCCI, T., HEWITSON, T.D. and MacLELLAN, D.G. (1997). Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice. Int. J. Biochem. Cell Biol. 29:191-200.
15. nd edition). Clark RAF (ed). Plenum Publishing Corporation, New York, pp 391-423.
16. DESMOULIÈRE, A., GEINOZ, A., GABBIANI, F. and GABBIANI, G. (1993). Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122:103-111.
17. DESMOULIERE, A., REDARD, M., DARBY, I.A. and GABBIANI, G. (1995). Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 146:55-66.
18. DESMOULIERE, A., DARBY, I.A. and GABBIANI, G. (2003). Normal and pathological soft tissue remodeling: role of the myofibroblast. With special emphasis on liver and kidney fibrosis. Lab. Invest. 83:1689-1707.
19. DE WEVER, O, and MAREEL, M. (2003). Role of tissue stroma in cancer cell invasion. J. Pathol. 200:429-447.
20. DONJACOUR, A.A. and CUNHA, G.R. (1991). Stromal regulation of epithelial function. Cancer Treat. Res. 53:335-564.
21. DUBUISSON, L., LEPREUX, S., BIOULAC-SAGE, P., BALABAUD, C., COSTA, A.M., ROSENBAUM, J. and DESMOULIÈRE, A. (2001). Expression and cellular localization of fibrillin-1 in normal and pathological human liver. J. Hepatol. 34:514-522.
22. DUBUISSON, L., MONVOISIN, A., NIELSEN, B.S., LE BAIL, B., BIOULAC-SAGE, P. and ROSENBAUM, J. (2000). Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma. J. Pathol. 190:190-195.
23. DUGINA, V., ALEXANDROVA, A., CHAPONNIER, C., VASILIEV, J. and GABBIANI, G. (1998). Rat fibroblasts cultured from various organs exibit differences in alpha-smooth muscle actin expression, cytoskeletal pattern and adhesive structure organisation. Exp. Cell Res. 238:481-490.
24. DVORAK, H.F. (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315:1650-1659.
25. FAOUZI, S., LE BAIL, B., NEAUD, V., BOUSSARIE, L., SARIC, J., BIOULAC-SAGE, P., BALABAUD, C. and ROSENBAUM, J. (1999). Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. J. Hepatol. 30:275-284.
26. FLETCHER, C.D. (1998). Myofibroblastic tumours: an update. Verh. Dtsch. Ges. Pathol. 82:75-82.
27. th edition). Schiff E, Sorrell M, and Maddrey W (eds). Lippincott-Raven, Philadelphia, pp 371-386.
28. FUTAKUCHI, M., HIROSE, M., OGISO, T., KATO, K., SANO, M., OGAWA, K. and SHIRAI, T. (1999). Establishment of an in vivo highly metastatic rat hepatocellular carcinoma model. Jpn. J. Cancer Res. 90:1196-1202.
29. HINDSON, V.J., ASHWORTH, J.L., ROCK, M.J., CUNLIFFE, S., SHUTTLEWORTH, C.A. and KIELTY, C.M. (1999). Fibrillin degradation by matrix metalloproteinases: identification of amino- and carboxy-terminal cleavage sites. FEBS Lett. 452:195-198.
30. HINZ, B., CELETTA, G., TOMASEK, J.J., GABBIANI, G. and CHAPONNIER, C. (2001a). Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol. Biol. Cell 12:2730-2741.
31. HINZ, B., MASTRANGELO, D., ISELIN, C.E., CHAPONNIER C. and GABBIANI, G. (2001b). Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am. J. Pathol. 159:1009-1020.
32. HINZ, B., GABBIANI, G. and CHAPONNIER C. (2002). The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J. Cell Biol. 157:657-663.
33. HINZ, B. and GABBIANI, G. (2003a). Cell-matrix and cell-cell contacts of myofibroblasts: role in connective tissue remodeling. Thromb. Haemost. 90:993-1002.
34. HINZ, B. and GABBIANI, G. (2003b). Mechanisms of force generation and transmission by myofibroblasts. Curr. Opin. Biotechnol. 14:538-546.
35. IREDALE, J.P. (2003). Cirrhosis: new research provides a basis for rational and targeted treatments. BMJ. 327:143-147.
36. ISHII, G., SANGAI, T., ODA, T., AOYAGI, Y., HASEBE, T., KANOMATA, N., ENDOH, Y., OKUMURA, C., OKUHARA, Y., MAGAE, J., EMURA, M., OCHIYA, T. and OCHIAI, A. (2003). Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem. Biophys. Res. Commun. 309:232-240.
37. IWANO, M., PLIETH, D., DANOFF, T.M., XUE, C., OKADA, H. and NEILSON, E.G. (2002). Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110:341-350.
38. JELASKA, A., STREHLOW, D. and KORN, J.H. (1999). Fibroblast heterogeneity in physiological conditions and fibrotic disease. Springer Semin. Immunopathol. 21:385-395.
39. JOHNSEN, M., LUND, L.R., ROMER, J., ALMHOLT, K. and DANO, K. (1998). Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr. Opin. Cell Biol. 10:667-671.
40. KALKA, C., MASUDA, H., TAKAHASHI, T., GORDON, R., TEPPER, O., GRAVEREAUX, E., PIECZEK, A., IWAGURO, H., HAYASHI, S.I., ISNER, J.M. and ASAHARA, T. (2000). Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ. Res. 86:1198-1202.
41. KALLURI, R. AND NEILSON, E.G. (2003). Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112:1776-1784.
42. KINNMAN, N., FRANCOZ, C., BARBU, V., WENDUM, D., REY, C., HULTCRANTZ, R., POUPON, R. and HOUSSET, C. (2003). The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab. Invest. 83:163-173.
43. KUNZ-SCHUGHART, L.A. and KNUECHEL, R. (2002a). Tumor-associated fibroblasts (part I): Active stromal participants in tumor development and progression? Histol. Histopathol. 17:599-621.
44. KUNZ-SCHUGHART, L.A. and KNUECHEL, R. (2002b). Tumor-associated fibroblasts (part II): Functional impact on tumor tissue. Histol. Histopathol. 17:623-637.
45. LEBAIL, B., FAOUZI, S., BOUSSARIE, L., GUIROUILH, J., BLANC, J.F., CARLES, J., BIOULAC-SAGE, P., BALABAUD, C. and ROSENBAUM, J. (1999). Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma. J. Pathol. 189:46-52.
46. LIEUBEAU, B., HEYMANN, M.F., HENRY, F., BARBIEUX, I., MEFLAH, K. and GREGOIRE, M. (1999). Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development. Int. J. Cancer 81:629-636.
47. LIU, K., HE, X., LEI, X.Z., ZHAO, L.S., TANG, H., LIU, L. and LEI, B.J. (2003). Pathomorphological study on location and distribution of Kupffer cells in hepatocellular carcinoma. World J. Gastroenterol. 9:1946-1949.
48. LIU, Y. (2004). Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J. Am. Soc. Nephrol. 15:1-12.
49. LORENA, D., DARBY, I.A., REINHARDT, D.P., SAPIN, V., ROSENBAUM, J. and DESMOULIÈRE, A. (2004). Fibrillin-1 expression in normal and fibrotic rat liver and in cultured hepatic fibroblastic cells: modulation by mechanical stress and role in cell adhesion. Lab. Invest. 84:203-212.
50. MATSUI, S., TAKAHASHI, T., OYANAGI, Y., TAKAHASHI, S., BOKU, S., TAKAHASHI, K., FURUKAWA, K., ARAI, F. and ASAKURA, H. (1997). Expression, localization and alternative splicing pattern of fibronectin messenger RNA in fibrotic human liver and hepatocellular carcinoma. J. Hepatol. 27:843-853.
51. MONVOISIN, A., BISSON, C., SI-TAYEB, K., BALABAUD, C., DESMOULIÈRE, A. and ROSENBAUM, J. (2002). Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells. Int. J. Cancer 97:157-162.
52. MONVOISIN, A., NEAUD, V., DE LÉDINGHEN, V., DUBUISSON, L., BALABAUD, C., BIOULAC-SAGE, P., DESMOULIÈRE, A. and ROSENBAUM, J. (1999). Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase. J. Hepatol. 30:511-518.
53. MURPHY-ULLRICH, J.E. (2001). The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J. Clin. Invest. 107:785-790.
54. NAKOPOULOU, L., GIANNOPOULOU, I., GAKIOPOULOU, H., LIAPIS, H., TZONOU, A. and DAVARIS, P.S. (1999). Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features. Hum. Pathol. 30:436-442.
55. NEAUD, V., FAOUZI, S., GUIROUILH, J., LE BAIL, B., BALABAUD, C., BIOULAC-SAGE, P. and ROSENBAUM, J. (1997). Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Hepatology 26:1458-1466.
56. NEAUD, V., HISAKA, T., MONVOISIN, A., BEDIN, C., BALABAUD, C., FOSTER, D.C., DESMOULIERE, A., KISIEL, W. and ROSENBAUM, J. (2000). Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells. J. Biol. Chem. 275:35565-35569.
57. NOEL, A., MUNAUT, C., NUSGENS, B., LAPIERE, C.M. and FOIDART, J.M. (1993). Different mechanisms of extracellular matrix remodeling by fibroblasts in response to human mammary neoplastic cells. Invasion Metastasis 13:72-81.
58. OGATA, R., TORIMURA, T;, KIN, M., UENO, T., TATEISHI, Y., KUROMATSU, R., SHIMAUCHI, Y., SAKAMOTO, M., TAMAKI, S., SATA, M. and TANIKAWA, K. (1999). Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 with tumor dedifferentiation in hepatocellular carcinomas. Hum. Pathol. 30:443-450.
59. OLASO, E., SALADO, C., EGILEGOR, E., GUTIERREZ, V., SANTISTEBAN, A., SANCHO-BRU, P., FRIEDMAN, S.L. and VIDAL-VANACLOCHA, F. (2003). Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology 37:674-685.
60. PETERSEN, O.W., NIELSEN, H.L., GUDJONSSON, T., VILLADSEN, R., RANK, F., NIEBUHR, E., BISSELL, M.J. and RONNOV-JESSEN, L. (2003). Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am. J. Pathol. 162:391-402.
61. PFAFF, M., REINHARDT, D.P., SAKAI, L.Y. and TIMPL, R. (1996). Cell adhesion and integrin binding to recombinant human fibrillin-1. FEBS Lett. 384:247-250.
62. POULSOM, R., PIGNATELLI, M., STETLER-STEVENSON, W.G., LIOTTA, L.A., WRIGHT, P.A., JEFFERY, R.E., LONGCROFT, J.M., ROGERS, L. and STAMP, G.W. (1992). Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am. J. Pathol. 141:389-396.
63. POWELL, D.W., MIFFLIN, R.C., VALENTICH, J.D., CROWE, S.E., SAADA, J.I. and WEST, A.B. (1999a). Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol. 277(1 Pt 1):C1-9.
64. POWELL, D.W., MIFFLIN, B.C., VALENTICH, J. D., CROWE, S.E., SAADA, J.I. and WEST, A.B. (1999b). Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am. J. Physiol. 277(2 Pt 1):C183-201.
65. REEVES, H.L. and FRIEDMAN, S.L. (2002). Activation of hepatic stellate cells - a key issue in liver fibrosis. Front. Biosci. 7:d808-d826.
66. ROSS, R., EVERETT, N.B. and TYLER, R. (1970). Wound healing and collagen formation. VI. The origin of the wound fibroblast studied in parabiosis. J. Cell Biol. 44:645-654.
67. SAGE, E.H. (2001). Regulation of interactions between cells and extracellular matrix: a command performance on several stages. J. Clin. Invest. 107:781-783.
68. SAKAMOTO, H., BROEKELMANN, T., CHERESH, D.A., RAMIREZ, F., ROSENBLOOM, J. and MECHAM, R.P. (1996). Cell-type specific recognition of RGD- and non-RGD-containing cell binding domains in fibrillin-1. J. Biol. Chem. 271:4916-4922.
69. SAPPINO, A.P., SKALLI, O., JACKSON, B., SCHÜRCH, W. and GABBIANI, G. (1988). Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int. J. Cancer. 41:707-712.
70. SCHMITT-GRÄFF, A., DESMOULIÈRE, A. and GABBIANI, G. (1994). Heterogeneity of myofibroblast phenotypic features: An example of of fibroblastic cell plasticity. Virchows Arch. 425:3-24.
71. SCHMITT-GRÄFF, A., SKALLI, O. and GABBIANI, G. (1989). Alpha-smooth muscle actin is expressed in a subset of bone marrow stromal cells in normal and pathological conditions. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 57:291-302.
72. SCHÜRCH, W., SEEMAYER, T.A. and GABBIANI, G. (1992). Myofibroblast. In Histology for Pathologists. Sternberg SS (ed). Raven Press, New York, pp 109-144.
73. SEEMAYER, T.A., LAGACE, R., SCHURCH, W. and TREMBLAY, G. (1979). Myofibroblasts in the stroma of invasive and metastatic carcinoma: a possible host response to neoplasia. Am. J. Surg. Pathol. 3:525-533.
74. SERINI, G., BOCHATON-PIALLAT, M.L., ROPRAZ, P., GEINOZ, A., BORSI, L., ZARDI, L. and GABBIANI, G. (1998). The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J. Cell Biol. 142:873-881.
75. SHAO, Z.M., NGUYEN, M. and BARSKY, S.H. (2000). Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 19:4337-4345.
76. SILZLE, T., RANDOLPH, G.J., KREUTZ M. and KUNZ-SCHUGHART, L.A. (2004). The fibroblast: Sentinel cell and local immune modulator in tumor tissue. Int. J. Cancer 108:173-180.
77. SKALLI, O., SCHÜRCH, W., SEEMAYER, T., LAGACE, R., MONTANDON, D., PITTET, B. and GABBIANI, G. (1989). Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab. Invest. 60:275-285.
78. SMITH, R.S., SMITH, T.J., BLIEDEN, T.M. and PHIPPS, R.P. (1997). Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am. J. Pathol. 151:317-322.
79. STRUTZ, F., OKADA, H., LO, C.W., DANOFF, T., CARONE, R.L., TOMASZEWSKI, J.E. and NEILSON, E.G. (1995). Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 130:393-405.
80. TEOFOLI, P., BARDUAGNI, S., RIBUFFO, M., CAMPANELLA, A., DE PITA', O. and PUDDU, P. (1999). Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars. J. Dermatol. Sci. 22:31-37.
81. THERET, N., MUSSO, O., TURLIN, B., LOTRIAN, D., BIOULAC-SAGE, P., CAMPION, J.P., BOUDJEMA, K. and CLEMENT, B. (2001). Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology 34:82-88.
82. TOCCANIER-PELTE, M.F., SKALLI, O., KAPANCI, Y. and GABBIANI, G. (1987). Characterization of stromal cells with myoid features in lymph nodes and spleen in normal and pathologic conditions. Am. J. Pathol. 129:109-118.
83. TOMASEK, J.J., GABBIANI, G., HINZ, B., CHAPONNIER, C. and BROWN, R.A. (2002). Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3:349-363.
84. TREDGET, E.E., SHANKOWSKY, H.A., PANNU, R., NEDELEC, B., IWASHINA, T., GHAHARY, A., TAERUM, T.V. and SCOTT, P.G. (1998). Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b. Plast. Reconstr. Surg. 102:1317-1328.
85. TSUJIMOTO, T., KURIYAMA, S., YAMAZAKI, M., NAKATANI, Y., OKUDA, H., YOSHIJI, H. and FUKUI, H. (2001). Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers. Int. J. Oncol. 18:41-47.
86. TSUKAMOTO, H., MISHIMA, Y., HAYASHIBE, K. and SASASE, A. (1992). Alpha-smooth muscle actin expression in tumor and stromal cells of benign and malignant human pigment cell tumors. J. Invest. Dermatol. 98:116-120.
87. TUCHWEBER, B., DESMOULIÈRE, A., BOCHATON-PIALLAT, M.L., RUBBIA-BRANDT, L. and GABBIANI, G. (1996). Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab. Invest. 74:265-278.
88. VRANA, J.A., STANG, M.T., GRANDE, J.P. and GETZ, M.J. (1996). Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family. Cancer Res. 56:5063-5070.
89. YAMADA, S., ICHIDA, T., MATSUDA, Y., MIYAZAKI, Y., HATANO, T., HATA, K., ASAKURA, H., HIROTA, N., GEERTS, A. and WISSE, E. (1992). Tenascin expression in human chronic liver disease and in hepatocellular carcinoma. Liver 12:10-16.
90. YANG, L., SCOTT, P.G., GIUFFRE, J., SHANKOWSKY, H.A., GHAHARY, A. and TREDGET, E.E. (2002). Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab. Invest. 82:1183-1192.